Isofol Medical AB (publ) (STO:ISOFOL)

Market Cap	229.79M -23.1%
Revenue (ttm)	n/a
Net Income	-55.57M
EPS	-0.22
Shares Out	320.49M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	146,994
Average Volume	568,133
Open	0.7200
Previous Close	0.7170
Day's Range	0.7110 - 0.7300
52-Week Range	0.5515 - 1.7380
Beta	0.92
RSI	55.03
Earnings Date	May 19, 2026

About Isofol Medical AB

Isofol Medical AB (publ) operates as a clinical stage biotech company. It develops arfolitixorin, which is in phase Ib/II clinical trial for the treatment of metastatic colorectal cancer. The company was incorporated in 2008 and is based in Gothenburg, Sweden.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 6
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: ISOFOL